<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39435694</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1462-3994</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>22</Day></PubDate></JournalIssue><Title>Expert reviews in molecular medicine</Title><ISOAbbreviation>Expert Rev Mol Med</ISOAbbreviation></Journal><ArticleTitle>Epigenetic changes in patients with post-acute COVID-19 symptoms (PACS) and long-COVID: A systematic review.</ArticleTitle><Pagination><StartPage>e29</StartPage><MedlinePgn>e29</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e29</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1017/erm.2024.32</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Up to 30% of people infected with SARS-CoV-2 report disabling symptoms 2 years after the infection. Over 100 persistent symptoms have been associated with Post-Acute COVID-19 Symptoms (PACS) and/or long-COVID, showing a significant clinical heterogeneity. To develop effective, patient-targeted treatment, a better understanding of underlying mechanisms is needed. Epigenetics has helped elucidating the pathophysiology of several health conditions and it might help unravelling inter-individual differences in patients with PACS and long-COVID. As accumulating research is exploring epigenetic mechanisms in PACS and long-COVID, we systematically summarized the available literature on the topic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We interrogated five databases (Medline, Embase, Web of Science, Scopus and medXriv/bioXriv) and followed PRISMA and SWiM guidelines to report our results.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight studies were included in our review. Six studies explored DNA methylation in PACS and/or long-COVID, while two studies explored miRNA expression in long-COVID associated with lung complications. Sample sizes were mostly small and study quality was low or fair. The main limitation of the included studies was a poor characterization of the patient population that made a homogeneous synthesis of the literature challenging. However, studies on DNA methylation showed that mechanisms related to the immune and the autonomic nervous system, and cell metabolism might be implicated in the pathophysiology of PACS and long-COVID.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Epigenetic changes might help elucidating PACS and long-COVID underlying mechanisms, aid subgrouping, and point towards tailored treatments. Preliminary evidence is promising but scarce. Biological and epigenetic research on long-COVID will benefit millions of people suffering from long-COVID and has the potential to be transferable and benefit other conditions as well, such as Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). We urge future research to employ longitudinal designs and provide a better characterization of included patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shekhar Patil</LastName><ForeName>Madhura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richter</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanning</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hendrix</LastName><ForeName>Jolien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pain in Motion (PAIN) Research Group, Department of Physiotherapy, Human Physiology, and Anatomy, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Foundation, Flanders (FWO).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wyns</LastName><ForeName>Arne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pain in Motion (PAIN) Research Group, Department of Physiotherapy, Human Physiology, and Anatomy, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrero Santiago</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Genetics, Pharmacology and Histology - University of Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nijs</LastName><ForeName>Jo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pain in Motion (PAIN) Research Group, Department of Physiotherapy, Human Physiology, and Anatomy, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godderis</LastName><ForeName>Lode</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>External Service for Prevention and Protection at Work (IDEWE), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8559-2217</Identifier><AffiliationInfo><Affiliation>Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pain in Motion (PAIN) Research Group, Department of Physiotherapy, Human Physiology, and Anatomy, Vrije Universiteit Brussel, Brussels, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Foundation, Flanders (FWO).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Mol Med</MedlineTA><NlmUniqueID>100939725</NlmUniqueID><ISSNLinking>1462-3994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA methylation</Keyword><Keyword MajorTopicYN="N">PACS</Keyword><Keyword MajorTopicYN="N">epigenetics</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">miRNAs</Keyword></KeywordList><CoiStatement>All authors have read the journal's policy on disclosure of potential conflicts of interest. The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>16</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39435694</ArticleId><ArticleId IdType="pmc">PMC11505605</ArticleId><ArticleId IdType="doi">10.1017/erm.2024.32</ArticleId><ArticleId IdType="pii">S1462399424000322</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Seyed Hosseini E et al. (2020) The novel coronavirus disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies. Virology 551, 1&#x2013;9. doi: 10.1016/j.virol.2020.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2020.08.011</ArticleId><ArticleId IdType="pmc">PMC7513802</ArticleId><ArticleId IdType="pubmed">33010669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren J (2023) Patients hospitalized with coronavirus disease 2019: a diverse population. Clinical Infectious Diseases 77, 558&#x2013;559. doi: 10.1093/cid/ciad280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad280</ArticleId><ArticleId IdType="pmc">PMC10893911</ArticleId><ArticleId IdType="pubmed">37255313</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H et al. (2021) Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study. BMC Infectious Diseases 21, 207. doi: 10.1186/s12879-021-05897-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05897-z</ArticleId><ArticleId IdType="pmc">PMC7903394</ArticleId><ArticleId IdType="pubmed">33627079</ArticleId></ArticleIdList></Reference><Reference><Citation>Wahlgren C et al. (2023) Two-year follow-up of patients with post-COVID-19 condition in Sweden: a prospective cohort study. Lancet Reg Health Eur 28, 100595. doi: 10.1016/j.lanepe.2023.100595</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100595</ArticleId><ArticleId IdType="pmc">PMC9951394</ArticleId><ArticleId IdType="pubmed">36855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB et al. (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. The Lancet. Infectious Diseases 22, e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M et al. (2021) Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Medicine 18, e1003773. doi: 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA et al. (2022) Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: a prospective, observational study. PLoS One 17, e0275274. doi: 10.1371/journal.pone.0275274</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0275274</ArticleId><ArticleId IdType="pmc">PMC9521913</ArticleId><ArticleId IdType="pubmed">36174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tene L et al. (2023) Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases 128, 3&#x2013;10. doi: 10.1016/j.ijid.2022.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.002</ArticleId><ArticleId IdType="pubmed">36529373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL et al. (2021) Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung 199, 113&#x2013;119. doi: 10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H et al. (2021) Long COVID-mechanisms, risk factors, and management. BMJ 374, n1648. doi: 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Dessie ZG and Zewotir T (2021) Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infectious Diseases 21, 855. doi: 10.1186/s12879-021-06536-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06536-3</ArticleId><ArticleId IdType="pmc">PMC8380115</ArticleId><ArticleId IdType="pubmed">34418980</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C et al. (2022) Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the long-COVID-EXP-CM multicenter study. Journal of Clinical Medicine 11, 413. doi: 10.3390/jcm11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C et al. (2022) Prevalence and risk factors of musculoskeletal pain symptoms as long-term post-COVID sequelae in hospitalized COVID-19 survivors: a multicenter study. Pain 163, e989&#x2013;e996. doi: 10.1097/j.pain.0000000000002564</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002564</ArticleId><ArticleId IdType="pubmed">34913880</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A et al. (2022) Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine 28, 1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM et al. (2022) Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Family Practice 39, 159&#x2013;167. doi: 10.1093/fampra/cmab076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A et al. (2022) Long COVID classification: findings from a clustering analysis in the predi-COVID cohort study. International Journal of Environmental Research and Public Health 19, 16018. doi: 10.3390/ijerph192316018</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316018</ArticleId><ArticleId IdType="pmc">PMC9740149</ArticleId><ArticleId IdType="pubmed">36498091</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson RC et al. (2023) Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae. Nature Medicine 29, 236&#x2013;246. doi: 10.1038/s41591-022-02107-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02107-4</ArticleId><ArticleId IdType="pmc">PMC9873574</ArticleId><ArticleId IdType="pubmed">36482101</ArticleId></ArticleIdList></Reference><Reference><Citation>Polli A et al. (2019) When environment meets genetics: a clinical review of the epigenetics of pain, psychological factors, and physical activity. Archives of Physical Medicine and Rehabilitation 100, 1153&#x2013;1161. doi: 10.1016/j.apmr.2018.09.118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2018.09.118</ArticleId><ArticleId IdType="pubmed">30352223</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdasco M and Esteller M (2019) Clinical epigenetics: seizing opportunities for translation. Nature Reviews Genetics 20, 109&#x2013;127. doi: 10.1038/s41576-018-0074-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-018-0074-2</ArticleId><ArticleId IdType="pubmed">30479381</ArticleId></ArticleIdList></Reference><Reference><Citation>AbdelHamid SG et al. (2021) Deciphering epigenetic(s) role in modulating susceptibility to and severity of COVID-19 infection and/or outcome: a systematic rapid review. Environmental Science and Pollution Research International 28, 54209&#x2013;54221. doi: 10.1007/s11356-021-15588-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-021-15588-6</ArticleId><ArticleId IdType="pmc">PMC8359636</ArticleId><ArticleId IdType="pubmed">34383213</ArticleId></ArticleIdList></Reference><Reference><Citation>Corley MJ et al. (2021) Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. Journal of Leukocyte Biology 110, 21&#x2013;26. doi: 10.1002/JLB.5HI0720-466R</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.5HI0720-466R</ArticleId><ArticleId IdType="pmc">PMC8013321</ArticleId><ArticleId IdType="pubmed">33464637</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro de Moura M et al. (2021) Epigenome-wide association study of COVID-19 severity with respiratory failure. EBioMedicine 66, 103339. doi: 10.1016/j.ebiom.2021.103339</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103339</ArticleId><ArticleId IdType="pmc">PMC8047083</ArticleId><ArticleId IdType="pubmed">33867313</ArticleId></ArticleIdList></Reference><Reference><Citation>Roustai Geraylow K et al. (2022) miRNA expression in COVID-19. Gene Reports 28, 101641. doi: 10.1016/j.genrep.2022.101641</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2022.101641</ArticleId><ArticleId IdType="pmc">PMC9288248</ArticleId><ArticleId IdType="pubmed">35875722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y et al. (2022) Comparative analysis of long non-coding RNA expression and immune response in mild and severe COVID-19. Frontiers in Molecular Biosciences 9, 835590. doi: 10.3389/fmolb.2022.835590</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.835590</ArticleId><ArticleId IdType="pmc">PMC9094366</ArticleId><ArticleId IdType="pubmed">35573725</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava S et al. (2023) Evaluation of altered miRNA expression pattern to predict COVID-19 severity. Heliyon 9, e13388. doi: 10.1016/j.heliyon.2023.e13388</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e13388</ArticleId><ArticleId IdType="pmc">PMC9889280</ArticleId><ArticleId IdType="pubmed">36743852</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Pato A et al. (2022) Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerging Microbes &amp; Infections 11, 676&#x2013;688. doi: 10.1080/22221751.2022.2038021</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2038021</ArticleId><ArticleId IdType="pmc">PMC8890551</ArticleId><ArticleId IdType="pubmed">35130828</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y et al. (2021) A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood. Scientific Reports 11, 7991. doi: 10.1038/s41598-021-86134-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86134-0</ArticleId><ArticleId IdType="pmc">PMC8041881</ArticleId><ArticleId IdType="pubmed">33846375</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastian-delaCruz M et al. (2021) The role of lncRNAs in gene expression regulation through mRNA stabilization. Non-Coding RNA 7, 3. doi: 10.3390/ncrna7010003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna7010003</ArticleId><ArticleId IdType="pmc">PMC7839045</ArticleId><ArticleId IdType="pubmed">33466464</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien J et al. (2018) Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9, 402. doi: 10.3389/fendo.2018.00402</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2018.00402</ArticleId><ArticleId IdType="pmc">PMC6085463</ArticleId><ArticleId IdType="pubmed">30123182</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A et al. (2021) Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. International Journal of Molecular Sciences 22, 6151. doi: 10.3390/ijms22116151</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116151</ArticleId><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Huoman J et al. (2021) Epigenome-wide DNA methylation profiling of healthy COVID-19 recoverees reveals a unique signature in circulating immune cells. medRxiv. 10.1101/2021.07.05.21260014</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.07.05.21260014</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y et al. (2022) Transcriptome and DNA methylome analysis of peripheral blood samples reveals incomplete restoration and transposable element activation after 3-months recovery of COVID-19. Frontiers in Cell and Developmental Biology 3, 1001558. doi: 10.3389/fcell.2022.1001558</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.1001558</ArticleId><ArticleId IdType="pmc">PMC9574079</ArticleId><ArticleId IdType="pubmed">36263014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y et al. (2022) EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Scientific Reports 12, 11478. doi: 10.1038/s41598-022-15467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15467-1</ArticleId><ArticleId IdType="pmc">PMC9261254</ArticleId><ArticleId IdType="pubmed">35798818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikesjo F et al. (2022) Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clinical Epigenetics 14, 172. doi: 10.1186/s13148-022-01398-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01398-1</ArticleId><ArticleId IdType="pmc">PMC9748378</ArticleId><ArticleId IdType="pubmed">36517875</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J et al. (2022) Persistent blood DNA methylation changes one year after SARS-CoV-2 infection. Clinical Epigenetics 14, 94&#x2013;94. doi: 10.1186/s13148-022-01313-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01313-8</ArticleId><ArticleId IdType="pmc">PMC9308917</ArticleId><ArticleId IdType="pubmed">35871090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali M et al. (2022) Role of circulatory miRNA-21 and associated signaling pathways in the pathogenesis of pulmonary fibrosis among individuals recovered after COVID-19 infection. Human Gene 34, 201093. doi: 10.1016/j.humgen.2022.201093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humgen.2022.201093</ArticleId><ArticleId IdType="pmc">PMC9329145</ArticleId><ArticleId IdType="pubmed">37521444</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Hidalgo MC et al. (2022) Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS. Emerging Microbes &amp; Infections 11, 1537&#x2013;1549. doi: 10.1080/22221751.2022.2081615</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2081615</ArticleId><ArticleId IdType="pmc">PMC9176679</ArticleId><ArticleId IdType="pubmed">35603455</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell M et al. (2020) Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ 368, l6890. doi: 10.1136/bmj.l6890</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l6890</ArticleId><ArticleId IdType="pmc">PMC7190266</ArticleId><ArticleId IdType="pubmed">31948937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekaert B et al. (2015) Improved age determination of blood and teeth samples using a selected set of DNA methylation markers. Epigenetics 10, 922&#x2013;930. doi: 10.1080/15592294.2015.1080413</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2015.1080413</ArticleId><ArticleId IdType="pmc">PMC4844214</ArticleId><ArticleId IdType="pubmed">26280308</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biology 14, R115. doi: 10.1186/gb-2013-14-10-r115</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2013-14-10-r115</ArticleId><ArticleId IdType="pmc">PMC4015143</ArticleId><ArticleId IdType="pubmed">24138928</ArticleId></ArticleIdList></Reference><Reference><Citation>Grasselli G et al. (2020) Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. The Lancet. Respiratory Medicine 8, 1201&#x2013;1208. doi: 10.1016/S2213-2600(20)30370-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30370-2</ArticleId><ArticleId IdType="pmc">PMC7834127</ArticleId><ArticleId IdType="pubmed">32861276</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. Journal of Experimental Medicine 207, 1589&#x2013;1597. doi: 10.1084/jem.20100035</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20100035</ArticleId><ArticleId IdType="pmc">PMC2916139</ArticleId><ArticleId IdType="pubmed">20643828</ArticleId></ArticleIdList></Reference><Reference><Citation>Polli A et al. (2019) Linking lifestyle factors to complex pain states: 3 reasons why understanding epigenetics may improve the delivery of patient-centered care. The Journal of Orthopaedic and Sports Physical Therapy 49, 683&#x2013;687. doi: 10.2519/jospt.2019.0612</Citation><ArticleIdList><ArticleId IdType="doi">10.2519/jospt.2019.0612</ArticleId><ArticleId IdType="pubmed">31570075</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton EW (2015) Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. JAMA 313, 1101&#x2013;1102. doi: 10.1001/jama.2015.1346</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman KJ et al. (2021) Our evolving understanding of ME/CFS. Medicina (Kaunas) 57, 200. doi: 10.3390/medicina57030200</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030200</ArticleId><ArticleId IdType="pmc">PMC7996879</ArticleId><ArticleId IdType="pubmed">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>White P (2020) Long COVID: don't consign ME/CFS to history. Nature 587, 197. doi: 10.1038/d41586-020-03136-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-03136-0</ArticleId><ArticleId IdType="pubmed">33173222</ArticleId></ArticleIdList></Reference><Reference><Citation>Samblas M, Milagro FI and Martinez A (2019) DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics 14, 421&#x2013;444. doi: 10.1080/15592294.2019.1595297</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15592294.2019.1595297</ArticleId><ArticleId IdType="pmc">PMC6557553</ArticleId><ArticleId IdType="pubmed">30915894</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels KB and Binder AM (2018) Considerations for design and analysis of DNA methylation studies. Methods in Molecular Biology 1708, 31&#x2013;46. doi: 10.1007/978-1-4939-7481-8_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7481-8_2</ArticleId><ArticleId IdType="pubmed">29224137</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KW and Pausova Z (2013) Cigarette smoking and DNA methylation. Frontiers in Genetics 4, 132. doi: 10.3389/fgene.2013.00132</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2013.00132</ArticleId><ArticleId IdType="pmc">PMC3713237</ArticleId><ArticleId IdType="pubmed">23882278</ArticleId></ArticleIdList></Reference><Reference><Citation>Niknam Z et al. (2022) Potential therapeutic options for COVID-19: an update on current evidence. European Journal of Medical Research 27, 6. doi: 10.1186/s40001-021-00626-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00626-3</ArticleId><ArticleId IdType="pmc">PMC8755901</ArticleId><ArticleId IdType="pubmed">35027080</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E et al. (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (London, England) 370, 1453&#x2013;1457. doi: 10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>